Objective: Adiponectin is an adipocyte-derived, antiatherogenic protein that is present in plasma as a large multimeric structure of high molecular weight (HMW) and in a trimer or hexamer form (non-HMW). The biological activities of these isoforms have not yet been elucidated. We therefore examined the effect of these isoforms on endothelial function in healthy young men.
Design: One hundred apparently healthy young men without overt cardiovascular disease (mean age 30 years) were recruited in this cross-sectional study based on voluntary enrollment.
Measurements: We evaluated endothelial function estimated by flow-mediated dilatation (FMD) of the brachial artery during reactive hyperaemia, and measured total and HMW adiponectin levels.
Results: Both HMW and non-HMW adiponectin levels showed a significant, inverse correlation with body mass index (BMI). FMD was significantly correlated with fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), malondialdehyde-modified low density lipoprotein (MDA-LDL), LDL particle size, and HMW adiponectin (r = 0.320, P = 0.001), but not non-HMW adiponectin (r = 0.125, P = 0.22). In multivariate analysis, HMW adiponectin and MDA-LDL were selected as independent factors capable of influencing FMD. No variables determined nitroglycerin-induced dilatation.
Conclusions: These results suggest that even in young men, plasma adiponectin levels can predict endothelial dysfunction before any overt vascular disease has occurred. HMW adiponectin may be more useful as a marker of endothelial dysfunction than total adiponectin.